CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $192,000 | +22.3% | 31,208 | +112.5% | 0.04% | +32.3% |
Q2 2018 | $157,000 | -40.8% | 14,687 | -40.6% | 0.03% | -41.5% |
Q1 2018 | $265,000 | +54.1% | 24,714 | +0.4% | 0.05% | +82.8% |
Q4 2017 | $172,000 | -45.4% | 24,625 | -44.3% | 0.03% | -37.0% |
Q3 2017 | $315,000 | – | 44,219 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |